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Antigen: a moiety exhibiting antigenicity; a substance recognized by an
existing immune response and associated molecules such as T-cells or
antibodies in a recall response. The antigen is typically, but not exclusively,
a protein or carbohydrate component of a pathogen and is recognized by a
component of the immune system.
B-cell epitopes: regions of the surface of a protein, or other biomacromolecule,
recognized by soluble or membrane-bound antibody molecules.
Cellular immunity: immune response mediated by T-cells that constantly
patrol the body seeking out foreign proteins originating from pathogens.
Conformational epitope: epitopic residues that are not arranged sequentially.
When a protein folds, the residues forming a conformational epitope are
juxtaposed, enabling the antibody to recognize its three-dimensional structure.
Continuous or linear epitope: a protein epitope consisting of 6 to 10 adjacent
amino acid residues.
Epitopes: isolated peptides; localised regions within larger protein structures,
carbohydrates, lipids or nucleotides – or a combination thereof.
Humoral immunity: immune responses mediated by B-cells via soluble or
membrane bound antibodies.
Immunogenicity: property of a molecular (protein, lipid or carbohydrate, or a
combination thereof), or supramolecular (virus, bacteria or protozoan para-
site), moiety that enables it to induce a significant response from the immune
system.
Immuno-informatics: a branch of bioinformatics focusing on immunology and
vaccinology.
Linear data: data structures in which insertion and deletion is possible in linear
fashion (e.g. arrays or linked lists).
Non-linear data: data structures in which linear insertion and deletion is not
possible (e.g. trees, graphs or stacks).
Protective antigen: an antigen that triggers a protective immune response.
Quantitative matrix (QM): this is essentially a refined motif. The matrix (X,Y)
represents the probability that an X residue will occur at a specific Y position.
Summation of position specific values, from the matrix, for a given peptide
yields the predicted binding score.Genome sequences from many organisms, including
humans, have been completed, and high-throughput
analyses have produced burgeoning volumes of ‘omics’
data. Bioinformatics is crucial for the management
and analysis of such data and is increasingly used to
accelerate progress in a wide variety of large-scale and
object-specific functional analyses. Refined algorithms
enable biotechnologists to follow ‘computer-aided strat-
egies’ based on experiments driven by high-confidence
predictions. In order to address compound problems,
current efforts in immuno-informatics and reverse vac-
cinology are aimed at developing and tuning integrative
approaches and user-friendly, automated bioinformatics
environments. This will herald a move to ‘computer-
aided biotechnology’: smart projects in which time-
consuming and expensive large-scale experimental
approaches are progressively replaced by prediction-
driven investigations.
Introduction
From ‘functional’ bioinformatics to computer-aided
biotechnology
In recent years, science has been characterized increas-
ingly by computer-aided research: projects implementing
early in silico analyses that shorten the length and
shape the direction of subsequent ‘wet-bench’ tasks. The
continuous flow of new genomic sequence and functional
annotation data from every taxonomic lineage permits
researchers to capture correlations based on large data-
sets, enabling the design of more-reliable analytical and
predictive tools. For example, the alignment of multiple
homologous sequences has helped in the identification of a
large number of structural and functional signatures:
protein domain profiles and pattern-based motifs indica-
tive of catalytic sites, ligand-binding sites, sorting signals
and more (for example, see [1–4]). This has generatedE-mail addresses: francesco.filippini@unipd.it, fmemf@bio.unipd.it
190 0167-7799/$ – see front matter  2007 Elsevier Ltdseveral integrated databases containing combined sets of
such signatures and of scanning tools capable of inferring
possible functions or regulatory mechanisms from the
presence of either canonical or degenerate signatures in
a sequence of interest. Such ‘sequence-to-function’
approaches [5] have enhanced the production of further
functional evidence by prediction-driven experiments.
Early examples included using the identification of specificT-cell epitopes: short peptides bound by MHC molecules and subsequently
recognized by T-cells.
. All rights reserved. doi:10.1016/j.tibtech.2007.12.006 Available online 21 February 2008
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to identify otherwise long-sought functions [6] as well as to
imply functions for disease gene products [7,8]. Later, more
complex, genome-wide analyses have led to the identifi-
cation of proteomic complements that underlie regulatory
pathways or interaction network organization in model
organisms [9,10]. This bioinformatics revolution has her-
alded the birth of ‘computer-aided biotechnology’.
Immuno-informatics as an example of computer-aided
biotechnology
The use of bioinformatics approaches to uncover functional
information has had a great impact on molecular immu-
nology and has enabled researchers in the field to address
biological and biotechnological problems by turning their
attention towards ‘compound problems’: problems that
require the integration of diverse lines of both in silico
and experimental evidence. With respect to sequence
analysis, this scaling-up strategy requires the availability
of reliably predicted features. To handle evidence diversity,
immuno-informatics (see Glossary) uses strategies that
span several areas of bioinformatics, including database
creation andmanagement [11,12], the definition and use of
functional and structural signatures, and the development
and use of predictive tools [12–14]. Moreover, a variety of
algorithmic approaches has been used to develop immuno-
informatic tools. The functional potential of these in silico
approaches has found its paradigm in reverse vaccinology
(RV, see below), an example of how rational integration
of reliable strategies has turned into synergetic and
applicative power. RV represented a revolution in immu-
nology and a milestone in biotechnology; it illustrated how
a compound biological problem such as vaccine design
could be solved by identifying, addressing and integrating
in silico several ‘sub-problems’ with a reasonable degree of
success [15].Figure 1. Molecular and cellular players in antigen presentation and recognition. Cellul
foreign proteins originating from pathogens. The uptake of an antigen is followed by int
are presented at the cell surface and are bound to major histocompatibility complex
selectivities and affinities; TCRs bind to MHCs, which are presented on the surfaces b
antigen recognition, yellow background box) that lies at the heart of both the adaptiveBelow, we highlight several of the most important pro-
blems from an immunological viewpoint, and the in silico
resources that can be used to address them. We then
present examples with applicative potential.
Databases and predictive tools
Molecular basis of the immune response
Immunogenicity (see Glossary) is among the most import-
ant and interesting properties within vaccine design and
discovery. In classifying measures of immunogenicity, it is
useful to distinguish between humoral and cellular immu-
nity (see Glossary). Antibodies mediate humoral immu-
nity; in cellular immunity, a complex system of proteins
converges on the interaction between major histocompat-
ability complexes (MHCs) and T-cell receptors (TCRs) (see
Figure 1). The TCR exhibits a wide range of selectivities
and affinities; TCRs bind MHCs that are presented on the
surfaces by other cells. These proteins bind small peptide
fragments derived from both host and pathogen proteins.
The recognition of such ternary complexes ofMHC, peptide
and TCR lies at the heart of the cellular immune response.
An antigen (see Glossary) can be recognized either as a
whole molecule by an antibody or as one or more peptide
fragments by the T-cell.
Identification of antigens relevant to the immune
response
A starting step towards reaching the goal of obtaining an
effective vaccine is the identification of an optimal compo-
sition of protective antigens (see Glossary) [16]. Both
proteins and capsule polysaccharides have been used as
protective antigens in various vaccine formulations but, in
the latter case, the need to cultivate the pathogen and the
emergence of molecular variations have made it difficult to
effectively sustain vaccine availability [17]. Hence, major
efforts worldwide are directed towards identifying andar immunity is mediated by T-cells, which constantly patrol the body, seeking out
racellular processing, which results in the production of small peptide epitopes that
(MHC) molecules (blue). The T-cell receptor (TCR, red) exhibits a wide range of
y other cells. It is recognition of such ternary MHC–peptide–TCR complexes (i.e.
, and memory, cellular immune response.
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screened expression libraries with patients’ antibodies.
However, the availability of complete genomic sequences
of pathogens and a plethora of new bioinformatics tools
have opened up new approaches to antigen identification.
The rationale used focuses on identification of a
pathogen’s surface proteins. The interactions between a
pathogen’s surface-exposed or secreted proteins and host
cells represent a pivotal step in pathogenesis and viru-
lence. In pathogens, several of the key players are proteins
involved in adhesion, invasion, secretion, signalling,
annulling host responses, toxicity, motility and lipopro-
teins [16,18]. Some protein classes, such as fimbriae, are
common to several species of pathogens, including Gram-
negative and Gram-positive bacteria, whereas others
are more specific. An effort is underway to elucidate the
structures of surface molecules so as to unravel the mol-
ecular mechanisms of interactions [19–21]. Figure 2 shows
a few examples of illustrated Protein Data Bank (PDB)
structures.Figure 2. Structures of surface-exposed and secreted proteins relevant to the pathog
pathogen classes. The following indicates the antigen’s name, pathogen’s species and P
(b) YadA, Yersinia pestis, 1p9h; (c) PapG, Escherichia coli, 1j8s; (d) PapE-PapK, Esch
falciparum, 1zrl; (g) AMA-1, Plasmodium vivax, 1w8k; (h) BoNT-B, Clostridium botu
epidermidis, 1r19; (k) SpnHl, Streptococcus pneumoniae, 1egu. Structural representatio
192Extensive research in the field defined several in silico
markers that provide a rational basis for prediction. Such
markers include regular expressions (sequence patterns)
and matrix-based profiles specific to surface localized
proteins. For example, the characterization of the trimeric
autotransporters in Gram-negative bacteria facilitates
their identification by a sequence profile [22], whereas a
profile including the LPxTG motif identifies cell-wall
anchoring domains in Gram-positives [23]. Finally, signa-
tures specific to antigen subfamilies have been reported,
such as two conserved motifs that characterize the ligand-
binding regions of cell wall-anchored adhesins called
MSCRAMMs (microbial surface components recognizing
adhesive matrix molecules) [24].
More general approaches for the identification of cell-
surface proteins exist, however. There are currently sev-
eral computational methods available for the prediction of
a protein’s subcellular localization (SCL). Given that tar-
geting of a protein to its ultimate destination is a complex
process, reliable SCL prediction can be challenged byen–host interface. Represented examples can be specific or common to different
DB codes, respectively, for each structure drawn: (a) OmpF, Escherichia coli, 1gfn;
erichia coli, 1n12; (e) Psv25, Plasmodium vivax, 1z27; (f) EBA127, Plasmodium
linum, 1epw; (i) InlA, Lysteria monocytogenes, 1O6T; (j) SdrG, Staphylococcus
ns were generated with PyMOL (http://www.pymol.org).
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approach to in silico analysis). Antigens can also be ident-
ified functionally. Adhesins, for example, mediate the first
essential step of interaction between a pathogen and its
cognate host receptor [25]. Therefore, developing strat-
egies to abrogate this step have attracted considerable
attention in recent years and several adhesins are cur-
rently being evaluated for inducing protective immunity.
Important examples include HpaA from Helicobacter
pylori [26], HMW1–HMW2-like adhesion proteins of
non-typeable Haemophilus influenzae [27], the RgpA-
Kgp proteinase-adhesin complex of Porphyromonas gingi-
valis [28,29], P97R1 adhesin from Mycoplasma hyopneu-
moniae [30], fibrinogen binding protein, fibronectin
binding protein A, clumping factor A and collagen adhesin
of Staphylococcus aureus [31], and FimH adhesin of
Escherichia coli [32].
Why predict epitopes? The importance of data collection
Antigens can be processed into fragments called epitopes
(see Glossary). The epitope is the immunological quantum,
the smallest recognizable molecular entity in the immune
system. Although the importance of non-peptide epitopes
is now increasingly well understood, peptidic B-cell and T-
cell epitopes (see Glossary), as mediated by the humoral or
cellular immune systems, respectively, remain the princi-
pal tools by which the complexity of immune responses
may be probed.MHCmolecules are extremely polymorphic
in their peptide-binding regions, and as a result, they
exhibit widely varying binding specificity. Furthermore,
different human leukocyte antigen (HLA) types are
expressed at dramatically different frequencies by differ-
ent ethnicities. A web-based tool to predict population
coverage of T-cell epitope-based diagnostics and vaccines
has been developed on the basis of MHC binding and/or T-
cell restriction data. Accordingly, epitope-based vaccines or
diagnostics can be designed to maximize population cover-
age, while minimizing complexity and variability of cover-
age obtained or projected in different ethnic groups [33].
It is the recognition of epitopes by T-cells, B-cells and
soluble antibodies that lies at the heart of the immune
response. Such recognition leads to activation of the cel-
lular and humoral immune systems and, ultimately, to the
effective destruction of pathogenic organisms. As the prin-
cipal components of both subunit and poly-epitopic
vaccines, the accurate prediction of B-cell and T-cell epi-
topes is thus a pivotal challenge for immuno-informatics.
Successful application of T-cell epitope identification is
now apparent in several areas: cancer therapy [34,35],
epitope-vaccine strategy against infective agents, in-
cluding HIV-1 [36], and from diagnostics [37] to allergic
and autoimmune diseases [38,39]. Predicted T-cell epi-
topes have recently been validated [40].
By incorporating detailed knowledge about antigen
processing into predictive methods, we can hope to signifi-
cantly improve the reliability of epitope identification.
Antigen presentation is a complex, multi-stage process.
Specific models for individual steps in the processing and
presentation pathway are available today. We can almost
track and predict the whole path from antigen to presented
epitope solely on the basis of its amino acid sequence.Proteasome restriction, binding to transporters associated
with antigen presentation (TAP), MHC loading and TCR
interaction can be modelled and incorporated into inte-
grated prediction tools [41–44]. Such tools are limited by
restricted experimental data [45], because the develop-
ment of predictive methods depends heavily on large,
accurate training sets [46]. This highlights the pivotal
importance of reliable, detailed epitope databases.
MHCPEP (MHC-binding peptides) [47] opened the way
to the collection of sensible, usable data. AntiJen [48],
MHCBN (MHC binders and non-binders) [49], BCIPEP
(B-cell immunodominant peptides) [50], HaptenDB [51]
and others have carried this work forward, several
resources to be made available on the web. The collection
of data concerning immune epitopes has been so crucial to
become a research field itself; the need for a large but very
reliable set of experimentally proved information puts the
researchers in front of the problem of scrupulously screen-
ing a huge amount of literature. The Immune Epitope
Database (IEDB) contains information on immune epi-
topes curated manually from the scientific literature,
and it makes public a large set of quantitative peptide-
binding affinity measurements relating to a set of different
human and mammalian MHC class I alleles. A dedicated
classifier was subsequently created to speed up the refer-
ence selection process without sacrificing sensitivity or
specificity of the human expert classification [52–54].
Methods and approaches in epitope identification
Using experimental approaches to calculate the affinity
between a givenMHCmolecule and an antigenic peptide is
both difficult and time-consuming. Thus, various compu-
tational methods have been developed for the purpose.
Initially, ‘direct’ methods (i.e. aimed at predicting T-cell
epitopes) were developed on the basis of the hypothesis
that peptides recognized by T cells have amphipathic
structures, with a hydrophobic side facing the MHC mol-
ecule and a hydrophilic side interacting with the TCR. The
AMPHI algorithm and SOHHA (strip-of-helix hydropho-
bicity algorithm) are examples of direct methods [14,55];
recently, a direct method for predicting cytotoxic T lympho-
cyte (CTL) epitopes was developed, implementing
machine-learning techniques that can discriminate T-cell
epitopes and non-epitope MHC binders [55]. The above
methods were superseded by the analysis of an MHC–
peptide complex by X-ray crystallography, which resolved
the extended conformation of a peptide bound to the MHC
groove [56]. Presently, most available methods are con-
sidered to be indirect, because they predict MHC binders
instead of T-cell epitopes. Current MHC binder prediction
methods are basedmainly onmotifs, quantitativematrices
(QMs, see Glossary), machine-learning techniques and ab
initio prediction.
In motif-based approaches, an MHC-binding peptide of
a particular allele is first examined for the presence of
motifs comprising specific ‘anchor residues’ at specific
‘anchor positions’. Antigen sequences are then scanned
for these motifs to detect MHC binders [14]. However, both
the absence of motifs in some MHC binders and the
possible presence of secondary anchor residues at non-
conserved positions can limit the usefulness of this193
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based ones, because they consider the contribution of each
residue at each position in the peptides, instead of anchor
positions and residues [57]; however, QM-based methods
fail to handle non-linearity (see Glossary) in data. In fact,
QMs are linear methods in which independent contri-
bution (to affinity) of each position (residue) is assumed.
Instead, real data are non-linear because they are not a
simple summation of individual contributions of residues
in binder. Machine-learning techniques have overcome
this limit [58,59], because they can handle non-linearity
in data and hence enable the prediction of MHC binders
with a high accuracy [60]. A current major constraint of
machine-learning techniques is that they require a large
training set ofMHC binder data, which is only available for
a limited albeit increasing number of MHC alleles. A large
dataset from the IEDB was used to establish a set of
benchmark predictions with one neural network method
and two matrix-based prediction methods [61]. Recently,
discriminant analysis and multiple linear regression have
been compared as algorithmic engines for the definition of
QMs for binding affinity prediction. A matrix integrating
the two methods proved powerfully predictive under cross-
validation [62]. In addition, certain ab initiomethodsmake
predictions on the basis of the structural binding of the
MHC molecule and peptides [63,64]. Such structure-based
predictions are limited by a high computational cost and
the need for three-dimensional imaging of the MHC-pep-
tide complex. However, advances in computational power
and the continuous flow of structural data are boosting
structure-based prediction of both B-cell and T-cell epi-
topes. DiscoTope is a novel method that uses protein three-
dimensional structural data for discontinuous epitope pre-
diction. It is based on amino acid statistics, spatial infor-
mation, and surface accessibility in a compiled dataset of
discontinuous epitopes determined by X-ray crystallogra-
phy of antibody–antigen protein complexes [65]. The
PePSSI (peptide-MHC prediction of structure through sol-
vated interfaces) algorithm has been developed for flexible
structural prediction of peptide binding toMHCmolecules.
Several peptides that PePSSI predicts to be strong HLA-
A2 binders are similarly predicted by another structure-
based algorithm, PREDEP (prediction of MHC class I
epitopes). Thus, structure-based prediction can identify
potential peptide epitopes without known binding motifs,
suggesting that side-chain orientation in binding peptides
can be obtained using PePSSI [66].
Vaccine design on the basis of antigen and epitope
identification
Epitope-based vaccine design A generally useful
synthetic vaccine might contain one or more T-cell and
B-cell epitopes, plus non-proteinaceous danger-signals.
Furthermore, it can be an artificial poly-epitope vaccine
or a natural antigen, possibly accompanied by adminis-
tration of an adjuvant. Nonetheless, all effective vaccines
engage directly with and are subsequently recognized by
effectors of immune memory. Long gone are the days when
vaccinology was a purely empirical endeavour. It is
important to understand the hows and the whys of the
immunological response to a pathogenic organism if we194are going to successfully manipulate them during the
design and development of new vaccines.
Vaccine design is also highly suited to the application of
in silico techniques, for both the discovery and develop-
ment of new and existing vaccines. The prediction of
promiscuous MHC binders is crucial for the design of
applicable subunit vaccines. The pioneering work from
Parker et al. [67] and Rammensee et al. [68] opened the
way to further investigations in this area. They developed a
method to predict the relative binding strengths of all
possible nonapeptides to MHC I molecules on the basis
of experimental peptide binding data [67], and they pro-
vided a first listing ofMHC ligands and peptidemotifs [68].
Severalmethodswere then developed to predict binders for
a large number of MHC I [57,69] and MHC II [70,71]
alleles. Further attempts have been made to develop com-
prehensive methods, and these also consider other com-
ponents involved in antigen processing, such as the
prediction of cleavage site [72,73] and TAP binders
[42,44,74]. Several methods – these are mostly based on
physiochemical properties – have been developed to pre-
dict continuous or linear and conformational epitopes (see
Glossary). For instance, BEPITOPE is aimed at predicting
the location of continuous B epitopes and patterns in
proteins [75], whereas the CEP (conformational epitope
prediction) server provides a web interface to a confor-
mational epitope prediction algorithm that, apart from
predicting conformational epitopes, also predicts antigenic
determinants and sequential epitopes [76]. Existing
methods are poor at predicting B-cell epitope [77,78],
and thus immuno-informaticians are developing new tools,
including machine-learning techniques [79]. Furthermore,
a standardization of data formats through a broader col-
laboration between groups has also been suggested [80].
The discovery of discontinuous B-cell epitopes is amajor
challenge in vaccine design. New structure-based methods
perform better at predicting residues of discontinuous
epitopes than do methods based solely on sequence infor-
mation. Predictions by suchmethods can guide experimen-
tal epitope-mapping in both the rational vaccine design
and the development of diagnostic tools, and might lead to
more efficient epitope identification [65].
Structure-based prediction of MHC–peptide association
can also be of help in cancer vaccine design, because
peptide vaccination for cancer immunotherapy requires
identification of peptide epitopes derived from antigenic
self-proteins associated with the tumour [66].
A combined immuno-informatics and structure-based
modelling approach was followed to develop T-cell epitope-
based vaccine design. MHCsim has been developed to
generate specific MHC–peptide complex structures and
to provide configuration files upon which to run molecular
modelling simulations. It enables the automated construc-
tion of both MHC–peptide structure files and the corre-
sponding configuration files required to execute a
molecular dynamics simulation [81].
The role of secretory proteins of Mycobacterium tuber-
culosis in pathogenesis and stimulation of specific host
responses is well documented. Therefore identification of
T-cell epitopes from this set of proteins might serve to
define candidate antigens with vaccine potential. A set of
Box 1. Machine-learning: how reliable data can affect tool development
The accuracy of a method depends on the technique and dataset used
for training.
An artificial neural network (ANN) is an information processing
architecture with three layers (input, hidden and output) of highly
interconnected neurons; each connection is associated with a weight.
Inspired by biological nervous system, ANNs have been widely used
for pattern recognition and classification. Each neuron is designed to
mimic its biological counterpart, accepting a weighted set of inputs
and responding with an output. After training with known examples,
the information for classification of new entities is stored in the form
of weights associated with the connections between neurons. ANN
allows development of a general classification method through which
one can predict with high accuracy even in the absence of similarity
between testing and training data. It can handle non-linear data and
can perform very well in cases with a large number of training
patterns. The major drawback is overfitting; in cases where learning
was performed for too long or where training examples are rare, the
learner may adjust to very specific random features of the training
data that have no causal relation to the target function. In this process,
the performance on the training examples still increases while the
performance on unseen data becomes worse.
A hidden Markov model (HMM) is a statistical model initially
developed for speech recognition and now widely used in bioinfor-
matics. AnHMM is a finite set of states, each of which is associatedwith
a (generally multidimensional) probability distribution. Transitions
among the states are governed by a set of transition probabilities. In
a particular state, an outcome or observation can be generated
according to the associated probability distribution. To an external
observer, only the outcome is visible; the state itself is ‘hidden’.
Support vector machines (SVMs) are universal approximators
based on statistical learning and optimization theory. They support
both regression and classification tasks and can handle multiple,
continuous and categorical variables. To construct an optimal hyper-
plane, SVMs employ an iterative training algorithm that is used to
minimize an error function. Hyperplanes are searched in the space of
possible inputs; subsequently, these hyperplanes are used to
separate positive and negative patterns. SVMs are based on statistical
learning, which has the capability to handle linearity and non-linearity
in a dataset. SVMs have minimum over-optimization even when
training with a limited number of patterns.
While preparing training datasets with sequences we need to
emphasize the following aspects: (i) quality, (ii) reliability, (iii)
diversity, (iv) size, (v) redundancy and (vi) blind datasets.
(i) Quality: use well-annotated (preferably experimentally validated)
data. It is best to avoid sequences with ambiguous annotation,
conflicting experimental evidence, or those that were annotated
through prediction themselves.
(ii) Reliability: it is preferable to collect sequences from reliable data
sources (e.g. SWISS-PROT, RefSeq). Preference should be given
to sequences annotated by more than one group or characterized
by direct experimental evidence.
(iii) Diversity: it is important to obtain sequences from diverse
sources (e.g. several species) to develop a widely applicable
method.
(iv) Size: performance displays a positive correlation with the size of
the dataset used for training. Thus attempts should be made to
collect as many sequences as possible to develop accurate
methods.
(v) Redundancy: redundant or highly similar sequences need to be
removed from datasets to avoid biasing the algorithm towards
groups of similar sequences.
(vi) Blind datasets: to avoid over-optimization, one should test a
newly developed method on a blind or independent dataset not
used in development of the method.
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computationally for the presence of HLA class I binding
nonameric peptides. All possible overlapping nonameric
peptide sequences from such secretory proteins were
generated in silico and analyzed for their ability to bind
to alleles belonging to the A, B and C loci of HLA class I.
The structural basis for recognition of nonamers by differ-
ent HLA molecules was studied by employing structural
modelling of HLA class I–peptide complexes. This yielded a
good correlation between structural analysis and binding
prediction. Pathogen peptides that could behave as self- or
partially self-peptides in the host were eliminated with the
use of a comparative study with the human proteome, thus
reducing the number of peptides for analysis [82].
The assessment of epitope conservation is dramatically
important. In vaccine design, a high level of conservation
can provide broader protection across multiple strains of
pathogens. In diagnostic analyses or in monitoring dis-
eases, a specific marker is obtained by looking for an
epitope with a low level of conservation. In both these
opposite cases, a tool for epitope conservation evaluation
is fundamental [83].
Antigen-based vaccine design Adhesins are key
molecules for the design of vaccines against microbial
infective agents [84]. The acellular pertussis vaccine,
currently approved for use against whooping cough
caused by Bordetella pertussis, contains the filamentous
adhesin hemagglutinin as one of its components [85].
Identification of adhesins and adhesin-like proteins
is experimentally arduous, making bioinformatics theideal strategy for their identification. Homology-based
approaches are powerful in quickly identifying homo-
logous sequences, but they can fail when the sequences
become diverse. To overcome this limitation, machine-
learning techniques and compositional features of
molecules have been used to develop several algorithms
that allow more focussed predictions. These algorithms
are non-homology methods based on sequence properties.
A step in this direction is the development of SPAAN
(software program for prediction of adhesins and adhesin-
like proteins using neural network) [86], which is based on
highly curated datasets and neural networks that were
optimally trained for compositional attributes (taking into
account the considerations described in Box 1). The final
probability of a given protein likely to be an adhesin is
the weighted average of individual probabilities emerging
from the five networks, based on the accuracy of each
network. Adhesins had not previously been discovered
in Mycobacterium tuberculosis, but SPAAN was able to
predict several adhesins, which were independently
confirmed by functional evidence; one example is
Rv1818c, which was shown to display adhesin-like
characteristics [87,88] and is being examined for vaccine
design now [89]. Thus, the search for candidate adhesin
proteins can be a most promising approach for identifying
novel vaccine candidates.
An alternative approach seeks to identify putative sub-
unit vaccines by finding antigens with genomic sequences;
VaxiJen uses an alignment-free approach to identify anti-
gens directly [90,91]. Instead of concentrating on predict-
ing antigenic regions, the method uses statistical models195
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bacterial, viral and tumour antigen datasets to predict
whole-protein antigenicity. VaxiJen has shown impressive
prediction accuracy of up to 89%.Whole-antigen prediction
is best used in conjunction to other methods within RV,
such as subcellular localization prediction.
Integrative approaches in immuno-informatics
Integrating predictive tools to challenge compound
problems
Early in silico predictive tools focused on using basic
computational techniques to identify simple sequence fea-
tures. The precision of these tools was improved thanks to
new computational techniques such as ‘approximate near-
est neighbor’ and ‘hidden Markov models’ (HMMs) (Box 1);
then, more complex methods were developed.
The first instances of these more complex approaches
came in the form of consensus algorithms for the improved
identification of secondary structure elements. The
strategy of combining the results of multiple methods into
a consensus prediction is still employed in current
methods. In the best examples, the predictive performance
of a consensus method can be up to 40% higher than the
performance of individual methods [92].
Integrative predictive strategies can be used to address
more challenging predictive tasks. Rather than using
multiple tools to predict the same sequence feature and
then combining those results into a high-confidence pre-
diction for that feature, multiple tools can be used to
predict multiple sequence features, and the results com-
bined to generate a prediction of a more complex biological
characteristic of interest, achieving higher precision than
ever before. This is crucial to biotechnological projects in
immuno-informatics, wherein in silico steps have to chal-
lenge compound problems at multiple levels (molecule,
cell, tissue, organ, organism and environment) rather than
predicting a specific molecular moiety. To ensure an ulti-
mately reliable prediction, both sequence features and
computational techniquesmust be carefully selected. Com-
plex biological attributes such as localization or function
can be influenced by amultitude of features, and it is worth
researching and including as many as possible to bolster a
method’s predictive success. It is important to consider, in
addition to features that are predictive of a specific charac-
teristic, those features that can be used to rule out one or
more potential classes. For example, the presence of a
signal peptide is insufficient to reliably assign a subcellular
localization, but it provides evidence that a protein is not
cytoplasmic.
Individual sequence feature prediction methods can
exhibit varying levels of performance, from quite precise
(few false positives) to less stringent (increased recall at
the expense of precision). In situations in which the pre-
cision of themethods to be integrated varies, the prediction
generated by each method should be weighted accordingly,
with more value placed on predictions generated by the
more precise techniques.
Integrative approaches in immuno-informatics
So far, bioinformatics research has developed and used a
wide range of integrative strategies and tools to infer196functional information. Tools to infer protein functions
are of outstanding interest to immuno-informaticians as
well as most to biotechnologists, and – in the never-ending
story of obtaining fine and reliable predictions – two recent
examples of integrative approaches can be presented. Pro-
teome Analyst [93] extracts keywords from a query
protein’s SwissProt record, or from the SwissProt records
of its nearest homologues. These keywords are then passed
to multiple classifiers, each of which has been trained to
classify a protein according to a particular feature. The
program outputs a list of features predicted for a query
protein, including function, active residues, interaction
partners, enzymatic activity, cofactors, localization, ontol-
ogies and several more. ProFunc [94] accepts three-dimen-
sional proteins structures as input and analyzes them at
both the sequence and the structural level for features such
as motifs, gene neighbours, conserved residues, folds, and
binding sites, all of which provide significant clues to the
protein’s unique function.
Given that protein function is strongly dependent on
subcellular localization (SCL), SCL predictors can also
play a pivotal role in basic and applied research projects.
For instance, these tools can rapidly and confidently
identify cell surface-exposed proteins, which represent
the most accessible pool of potential vaccine targets (see
next section).
Reliable prediction of protein SCL is best tackled by
integrative approaches, because targeting of a protein to
its ultimate destination is influenced by, or correlatedwith,
multiple sequence features, such as signal peptides, mem-
brane-spanning regions, functional motifs and differences
in amino acid composition unique to specific cellular com-
partments. Computationally identifying one of these fea-
tures alone is not sufficient to infer where a protein is
targeted to within a cell. However, by identifying several
such features in a protein – some of these might support a
specific SCL, others might rule out other cellular compart-
ments – enough information can be gathered to make a
reliable assessment of a protein’s likely localization.
PSORTb represents an example of an integrative environ-
ment able to yield extremely high-precision predictions of
the location to which a bacterial protein is ultimately
targeted [95]. In fact, the precision of certain integrative
localization prediction methods, including PSORTb, has
now surpassed that of high-throughput proteomics tech-
niques [96]. For a list of further SCL predictors, and
PSORT versions other than PSORTb, see supplementary
material or http://www.psort.org.
On the basis of the results of comparative evaluations of
multiple predictors [95,96], it has been recommended that
users wishing to infer the cell-surface proteome carry out
their analysis using PSORTb [97] for bacterial proteins, or
Proteome Analyst for eukaryotic proteins [98]. These
methods, at the time of evaluation, displayed the lowest
false-positive rates both overall and for the localization
sites in question, and their robust approach to prediction
and simple user-interfacesmakes them ideal for both small
and large-scale analysis.
Prediction of a bacterial surface proteome was crucial
for the beginning of the RV story and represented an
example of how an in silico step can replace large exper-
Box 2. Foundations of a reverse vaccinology in silico environment
The underlying principles governing RV projects can be described as
follows: (i) surface exposure of antigens is a fundamental requirement
for the host–pathogen interaction; (ii) antigen conservation among
different pathogen strains and serotypes should be taken into account
to formulatewidely protective vaccines. Recently, this has emerged as a
central issue; group B Streptococcus, a multi-serotype bacterial
pathogen, can adopt gene variability as a way to escape the immune
response [104]. This variability makes it unlikely that a single universal
protective antigen will be identified, and thus suggests that a
combination of different antigens in a vaccine formulation is required;
a high level of conservation among these antigens is the only way to
achieve broad protection; (iii) the absence of molecular mimicry
between vaccine candidates and human proteins is a must to avoid
poor immunogenicity or autoimmunity. The need to avoid such
problems was actually the driving force behind the conception of the
RV approach; (iv) when present, sequence homology to proteins
associated with virulence or immunogenicity is a strong element for
antigen selection, regardless of SCL prediction; another related
principle is (v), the absence of antigens in non-pathogenic strains,
such that antigens that are specific to pathogenic strains are selected as
putatively correlating with virulence; (vi) the ease of high-throughput
heterologous expression is also an important element to consider [15].
Following the expression difficulties in the Neisseria meningitidis
experiment, a cut-off of two and four transmembrane helices was
applied to the RV studies of Chlamydia pneumoniae and Bascillus
anthracis, respectively (multiple transmembrane helices can be
indicative of a surface-exposed SCL, but, conversely, they are known
to impair heterologous expression in E. coli).
Beyond these in silico criteria, DNA microarray analyses have
been taken into consideration to tell us whether, when and to what
extent antigens are expressed in vitro and in vivo during infection.
A step forward is to integrate, standardize, and automate analyses
in order: (i) to minimize time costs in the process of vaccine candidate
identification, without losing efficiency, but rather producing more
information for finer discrimination and (ii) to provide the community
with an accessible, dedicated RV environment. So far, NERVE (New
Enhanced Reverse Vaccinology Environment) [105] represents the
only attempt to bring together a similar body of principles into an
automated pipeline resembling an RV process. Antigens are anno-
tated according to multiple classification methods: (i) SCL prediction,
(ii) adhesin probability (Pad), (iii) number of transmembrane domains,
(iv) homology to human proteins, (v) conservation in related strains,
and (vi) putative function. A cut-off-based selection provides a final
pool of vaccine candidates. This bundling of predictors illustrates the
possibility of obtaining narrow vaccine candidate pools that are
highly enriched in protective antigens. The flexibility of a modular RV
environment allows for the inclusion of novel features likely to
strengthen the capacity to represent biosequences as objects seen
under the light of vaccine design, for example, the inclusion of more
putative antigen features to be weighted in a score-based system.
Quantitative methods can tell us not only which antigen is predicted
to be vaccine candidate but also how suitable that seems to be. Then,
the refinement of the classifying system is expected to further
maximize the treatment of issues such as the risk of autoimmunity
and ease of experimental steps, as well as new eventual questions
that may prove relevant to antigen selection.
Review Trends in Biotechnology Vol.26 No.4imental tasks; thus, it is clear that improved precision and
reliability in the prediction of surface protein topology and
class can further boost RV projects.
Reverse vaccinology
RV represents a successful and complete example of a
computer-aided biotechnology. The availability of
pathogen genomes and a pool of robust sequence analysis
tools made it possible to implement the search for vaccine
candidates on a genome scale as an in silico process [99].
Initially conceived as a way to escape major limitations in
conventional experimental approaches, RV has become the
standard approach to vaccine discovery in the current post-
genomic era. Unlike the conventional identification of
protective antigens amongst components of cultured
pathogens, RV makes use of the whole spectrum of poten-
tial antigens. This allows vaccinologists to obtain pools of
vaccine candidates that also include antigens that other-
wise would be missed either because of poor or absent
expression in vitro or because of the impossibility of cultur-
ing the pathogen. A reservoir of previously unrecognized
vaccine candidates was instrumental in formulating a
vaccine against Neisseria meningitidis serogroup B
(MenB). Indeed, this pathogen subgroup was the only
one whose surface-exposed polysaccharides were not
included in the vaccines developed thus far. This is because
of their significant similarity to human targets, which
might potentially lead to weak immunogenicity or even
autoimmunity. Sequencing the MenB genome and per-
forming sequence alignment, motif scanning and SCL
prediction analyses resulted in the identification of 570
putative surface-exposed proteins. Cloning and expression
was unsuccessful for 220 of them, showing that it is
important to take into account the relative ease of thehigh-throughput steps at the in silico stage. Serological
analysis finally highlighted five vaccine candidates. This
groundbreaking work kick-started the RV era in 2000 [15]
and introduced a foundational approach for the in silico
selection of vaccine candidates [100]. Since then, further
RV projects from different groups around the world con-
firmed the validity of the ‘reverse’ approach and produced
many vaccine candidates that showed promising preclini-
cal results [101,102]. However, the manual curation of the
in silico selection steps resulted in a certain variability in
the methodologies applied (see supplemental Table S2).
The need to standardize and automate RV resulted in the
creation of a dedicated, new environment (see Box 2).
Conclusions
The continuous flow of ‘omics’ data and functional evidence
from small-, medium- and large-scale ‘basic science’ and
biotechnological projects is allowing bioinformaticians to
move towards knowledge-based classification. Recently,
sequence data from multiple strains of a single pathogen
have enabled us to decipher virulence mechanisms. The
comparison of multiple strains of a single species defines a
‘pan-genome’: a measure of the total gene repertoire that
can pertain to a givenmicrobial species. This will enable us
to use a knowledge-based approach for the identification of
vaccine candidates [103].
Improved computational techniques and combined inte-
grative strategies are now able to provide researchers with
high-confidence predictions for complex biological charac-
teristics. This will herald a move to ‘computer-aided bio-
technology’: prediction-driven smart projects in which
time-consuming and expensive large-scale experimental
approaches are progressively replaced by ‘functional bioin-
formatics’ investigations. To date, immuno-informatics197
Review Trends in Biotechnology Vol.26 No.4represents a powerful example of the functional bioinfor-
matics approach. Reverse vaccinology demonstrates how
immuno-informatics can and will underpin biotechnologi-
cal research. The development of novel tools dedicated to
the RV environment will help us address various sensible
questions: to what extent, other than gene expression, are
surface antigens actually accessible, considering antigen
masking and protein degradation etc.? What does the
antigen look like after eventual post-translation modifi-
cation, especially in eukaryotic pathogens? How can we
predict the best combination of vaccine candidates for a
polyvalent vaccine formulation? Upon the analysis of the
results obtained by the past RV works, the possibility of
addressing these questions will greatly boost vaccine
design in the future.
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